Tower Research Capital LLC (Trc) Inhibrx, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.76 - $39.56 $171,629 - $207,254	-5,239 Reduced 92.94%	398 $13,000
Q4 2023 Feb 13, 2024	SELL	$14.5 - $38.0 $3,900 - $10,222	-269 Reduced 4.55%	5,637 $214,000
Q3 2023 Nov 14, 2023	BUY	$15.75 - $26.31 $54,668 - $91,322	3,471 Added 142.55%	5,906 $108,000
Q2 2023 Aug 14, 2023	SELL	$16.96 - $27.82 $66,364 - $108,859	-3,913 Reduced 61.64%	2,435 $63,000
Q1 2023 May 09, 2023	BUY	$18.45 - $27.14 $26,051 - $38,321	1,412 Added 28.61%	6,348 $120,000
Q4 2022 Feb 10, 2023	SELL	$20.18 - $33.33 $14,469 - $23,897	-717 Reduced 12.68%	4,936 $121,000
Q3 2022 Nov 10, 2022	BUY	$11.58 - $24.73 $12,911 - $27,573	1,115 Added 24.57%	5,653 $101,000
Q2 2022 Aug 15, 2022	BUY	$8.52 - $25.26 $27,076 - $80,276	3,178 Added 233.68%	4,538 $52,000
Q1 2022 May 12, 2022	SELL	$19.89 - $43.18 $16,071 - $34,889	-808 Reduced 37.27%	1,360 $30,000
Q4 2021 Feb 14, 2022	BUY	$26.75 - $46.02 $50,851 - $87,484	1,901 Added 711.99%	2,168 $95,000
Q3 2021 Nov 15, 2021	SELL	$25.18 - $37.81 $15,762 - $23,669	-626 Reduced 70.1%	267 $9,000
Q2 2021 Aug 16, 2021	SELL	$14.69 - $27.52 $4,333 - $8,118	-295 Reduced 24.83%	893 $25,000
Q1 2021 May 17, 2021	BUY	$16.27 - $41.26 $6,735 - $17,081	414 Added 53.49%	1,188 $24,000
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $12,353 - $38,700	774 New	774 $26,000

18.6K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $586M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.